A number of other brokerages have also weighed in on MCK. Bank of America decreased their target price on McKesson from $179.00 to $172.00 and set a buy rating for the company in a research report on Wednesday, April 11th. Royal Bank of Canada decreased their target price on McKesson to $158.00 and set a market perform rating for the company in a research report on Friday, June 29th. ValuEngine lowered McKesson from a hold rating to a sell rating in a research report on Tuesday, May 22nd. Barclays initiated coverage on McKesson in a research report on Thursday, March 8th. They set an equal weight rating and a $165.00 target price for the company. Finally, Leerink Swann set a $160.00 target price on McKesson and gave the company a market perform rating in a research report on Tuesday, May 29th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $172.70.
Shares of MCK stock opened at $134.57 on Tuesday. McKesson has a 52-week low of $131.43 and a 52-week high of $178.86. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.57. The company has a market cap of $27.22 billion, a P/E ratio of 10.66, a price-to-earnings-growth ratio of 1.26 and a beta of 1.29.
McKesson (NYSE:MCK) last issued its quarterly earnings results on Thursday, May 24th. The company reported $3.49 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $3.56 by ($0.07). McKesson had a return on equity of 23.55% and a net margin of 0.03%. The business had revenue of $51.63 billion for the quarter, compared to the consensus estimate of $51.36 billion. During the same period in the prior year, the business posted $3.41 earnings per share. McKesson’s revenue was up 6.0% on a year-over-year basis. research analysts expect that McKesson will post 13.35 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, July 2nd. Stockholders of record on Friday, June 1st were issued a $0.34 dividend. The ex-dividend date of this dividend was Thursday, May 31st. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.01%. McKesson’s dividend payout ratio is presently 10.78%.
In other news, SVP Erin M. Lampert sold 868 shares of McKesson stock in a transaction on Wednesday, May 30th. The stock was sold at an average price of $142.00, for a total value of $123,256.00. Following the transaction, the senior vice president now directly owns 64 shares in the company, valued at approximately $9,088. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.87% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the stock. Altavista Wealth Management Inc. grew its stake in McKesson by 2.2% during the 1st quarter. Altavista Wealth Management Inc. now owns 15,836 shares of the company’s stock worth $2,231,000 after buying an additional 335 shares during the last quarter. Insight 2811 Inc. grew its stake in McKesson by 24.2% during the 1st quarter. Insight 2811 Inc. now owns 1,886 shares of the company’s stock worth $266,000 after buying an additional 367 shares during the last quarter. Jacobi Capital Management LLC grew its stake in McKesson by 61.5% during the 1st quarter. Jacobi Capital Management LLC now owns 985 shares of the company’s stock worth $138,000 after buying an additional 375 shares during the last quarter. Brinker Capital Inc. grew its stake in McKesson by 5.5% during the 1st quarter. Brinker Capital Inc. now owns 7,926 shares of the company’s stock worth $1,117,000 after buying an additional 415 shares during the last quarter. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in McKesson by 0.7% during the 1st quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 58,845 shares of the company’s stock worth $8,289,000 after buying an additional 424 shares during the last quarter. Hedge funds and other institutional investors own 90.17% of the company’s stock.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.